Učitavanje...
Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism
BACKGROUND: Treatment of severe diffuse congenital hyperinsulinism (CHI) without sufficient response to diazoxide is complicated by the lack of approved drugs. Therefore, patients are often hospitalized long-term or have to undergo pancreatic surgery if episodes of severe hypoglycaemia cannot be pre...
Spremljeno u:
| Izdano u: | Orphanet J Rare Dis |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455078/ https://ncbi.nlm.nih.gov/pubmed/28576129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0653-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|